Tag: Continuous Glucose Monitor (CGM)
Ascensia, Senseonics launch ad campaign
October 11, 2023HME News Staff
PARSIPPANY, N.J., and GERMANTOWN, Md. – Ascensia Diabetes Care and Senseonics Holdings have launched a new U.S. advertising and marketing campaign for the Eversense E3 CGM System. The “CGM for Real Life” campaign seeks to drive awareness of the Eversense E3, a six-month, implantable sensor, as well as the everyday challenges people with diabetes face. “This campaign is designed to challenge the status quo in continuous glucose monitoring, which for too long has meant self-insertion...
Best Buy cracks into prescription-based medical devicesÂ
October 10, 2023HME News Staff
RICHFIELD, Minn. – Best Buy will sell the Dexcom G7 continuous glucose monitoring system (CGM) to eligible customers through BestBuy.com, where they will be brought to a new platform, Wellness.BestBuyHealth.com, to complete the process.
It’s the first time the electronics giant will offer prescription-based medical devices to customers.
“Through our health and wellness categories at Best Buy, we make it easy to purchase any of our thousands of carefully curated...
Abbott, WeightWatchers team up on new appÂ
September 19, 2023HME News Staff
ABBOTT PARK, Ill., and NEW YORK – Abbott and WeightWatchers have announced the availability of a connected app to help people living with diabetes understand how food and activity impact their glucose levels. WW members who follow the WW Diabetes-Tailored Plan can now access their glucose data from Abbott’s FreeStyle Libre 2, a continuous glucose monitoring system, within their WW app. "Clinical data shows that healthy weight loss leads to a reduction of average glucose, which is important...
Ascensia: ‘This is Diabetes, This is Real’Â
September 19, 2023HME News Staff
PARSIPPANY, N.J. – Ascensia Diabetes Care, owner of the CONTOUR blood glucose monitoring system portfolio and exclusive distributor of the Eversense continuous glucose monitoring system, has opened submissions for its art and photo competition in support of World Diabetes Day 2023. The theme of this year’s competition is “This is Diabetes, This is Real,” aiming to capture the challenges, successes and day-to-day realities of people living with diabetes. “For our 2023...
GoodRx hits milestone for diabetesÂ
August 15, 2023HME News Staff
SANTA MONICA, Calif. - GoodRx says it has helped almost 2.5 million Americans save more than $500 million on diabetes treatments to date. The company says, for example, that its customers saved, on average, 37% on continuous glucose monitors, including the Dexcom G6 and G7, FreeStyle Libre, Libre 2 and Libre 3. “Managing a chronic condition can be incredibly expensive and time consuming – so much so, we’ve seen the cost of supplies and prescriptions used to manage diabetes...
Disruption, innovation and growth in first half of 2023
July 18, 2023Liz Beaulieu, Editor
We’ve burned through the first half of 2023 already and what do we have to show for it?
If the most read stories from January through June are any indication, it’s disruption, innovation and growth.
Let’s start with disruption. It has come in a number of forms in 2023, including one of the HME industry’s legacy manufacturers, Invacare, filing for bankruptcy. We posted a story about that to our website in February, and it remains the most read story of the...
In brief: AdaptHealth’s new CEO, CGM-nutrition connection, O&P billÂ
June 28, 2023HME News Staff
PLYMOUTH MEETING, Pa. - AdaptHealth’s board of directors has named Lincare’s Crispin Teufel as its next CEO.
Teufel, who has served as CEO of Lincare since July 2017, is expected to assume his role at AdaptHealth on Sept. 1.
“We are quite pleased to be announcing the appointment of Crispin Teufel as the next CEO of AdaptHealth,” said Richard Barasch, chairman of the board. “Crispin is the ideal candidate to lead AdaptHealth in its mission to transform...
Senseonics’ Eversense E3 offers accurate 365-day performance
June 28, 2023HME News Staff
GERMANTOWN, Md. – Senseonics Holdings highlighted new clinical data demonstrating the safety and accuracy of its Eversense E3 CGM system during a presentation at the American Diabetes Association 83rd Scientific Session. “These data further bolster Eversense’s position as a leading CGM choice for people with diabetes,” said Francine Kaufman, M.D., Senseonics chief medical officer. “These recent studies are an important step forward as we continue to expand awareness...
Abbott funds research on CGM-nutrition connectionÂ
June 27, 2023HME News Staff
ABBOTT PARK, Ill., and ARLINGTON, Va. – Abbott is providing a $2.65 million grant over the next three years to the American Diabetes Association to enable the ADA to, among other things, launch two pilot programs targeted at adults with Type 2 diabetes to gain a deeper understanding of the role a continuous glucose monitoring (CGM) system can play in personalized therapeutic nutrition.
These programs will leverage CGM data to understand how they help people with diabetes achieve their...
Providers race to get physicians up to speed on CGMsÂ
June 16, 2023Theresa Flaherty, Managing Editor
YARMOUTH, Maine – Diabetes providers are striving to fill an information gap for referral sources who may not be familiar yet with changes to Medicare policy that expanded coverage for continuous glucose monitors (CGMs).
“Some (referral sources) are off to the races, but there’s a large number of members of the medical community that don’t know (about the changes),” said Matt Gallagher, CEO of Utah-based JQ Medical. “I think the industry is working through...